Discovery Labs to Present at 2012 Piper Jaffray Health Care Conference

Discovery Labs to Present at 2012 Piper Jaffray Health Care Conference

WARRINGTON, Pa., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Discovery Laboratories,
Inc. (Nasdaq:DSCO), a specialty biotechnology company dedicated to advancing a
new standard in respiratory critical care, today announced that management
will present an overview and update on the Company's business at the 2012
Piper Jaffray Health Care Conference on Tuesday, November 27, 2012 at 12:50 pm
ET at the New York Palace Hotel in New York, New York.

ABOUT DISCOVERY LABS

Discovery Laboratories, Inc. is a specialty biotechnology company with one
focus – to advance a new standard in respiratory critical care. Discovery
Labs' novel proprietary KL4 surfactant technology produces a synthetic,
peptide-containing surfactant that is structurally similar to pulmonary
surfactant and is being developed in liquid, lyophilized, and aerosolized
dosage forms. Discovery Labs is also developing its proprietary drug delivery
technologies to enable efficient delivery of aerosolized KL4 surfactant and
other inhaled therapies. Discovery Labs believes that its proprietary
technologies make it possible, for the first time, to develop a significant
pipeline of products to address a variety of respiratory diseases for which
there frequently are few or no approved therapies.For more information,
please visit our website at www.Discoverylabs.com.

CONTACT: Investor Relations
         Michael Rice, LifeSci Advisors:
         646.597.6979 or mrice@lifesciadvisors.com
         John G. Cooper, President and Chief Financial Officer:
         215.488.9490

Discovery Labs Logo
 
Press spacebar to pause and continue. Press esc to stop.